Search Results - "MOURER, Jacqueline S"
-
1
Randomized Trial Comparing Late Concentration-Controlled Calcineurin Inhibitor or Mycophenolate Mofetil Withdrawal
Published in Transplantation (15-05-2012)“…Early calcineurin inhibitor (CNI) withdrawal with mycophenolate mofetil (MMF) has not become routine practice, due to concerns about excess acute rejection…”
Get full text
Journal Article -
2
Impact of Late Calcineurin Inhibitor Withdrawal on Ambulatory Blood Pressure and Carotid Intima Media Thickness in Renal Transplant Recipients
Published in Transplantation (15-07-2013)“…BACKGROUNDCalcineurin inhibitors (CNIs) have an unfavorable cardiovascular risk profile in renal transplant recipients. The aim of this substudy was to assess…”
Get full text
Journal Article -
3
Late Calcineurin Inhibitor Withdrawal Prevents Progressive Left Ventricular Diastolic Dysfunction in Renal Transplant Recipients
Published in Transplantation (15-10-2012)“…Calcineurin inhibitor (CNI)-based therapy is associated with adverse cardiovascular effects. We examined the effects of late CNI or mycophenolate mofetil (MMF)…”
Get full text
Journal Article -
4
Treatment failure in Haemophilus influenzae due to a beta-lactamase low-level ampicillin-resistant organism
Published in The Journal of infection (01-12-2008)“…Summary Haemophilus influenzae is a rare causative organism of vertebral osteomyelitis in an adult. Cases reported in the literature were mainly caused by…”
Get full text
Journal Article -
5
Peptide-pulsed dendritic cells induce tumoricidal cytotoxic T lymphocytes from healthy donors against stably HLA-A0201-binding peptides from the Melan-A/MART-1 self antigen
Published in European journal of immunology (01-08-1996)“…The melanoma antigen Melan-A/MART-1 was screened for the presence of potential HLA-A*0201-binding cytotoxic T lymphocytes (CTL) epitopes. The immunodominant…”
Get more information
Journal Article -
6
Induction and characterization of cytotoxic T-lymphocytes recognizing a mutated p21ras peptide presented by HLA-A0201
Published in International journal of cancer (04-05-1995)“…The ras oncogene is frequently found to be activated in human cancer through point mutations at codons 12, 13 or 61. We explored whether these altered p21ras…”
Get more information
Journal Article